Financials · mywealthgrid

Standalone figures · ₹ crore · years without a filed annual are summed from quarters

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	114	130	125	128	74	72	76	123	152	214	232
COGS	—	-42	79	45	31	9	11	6	9	9	16
Gross profit	—	—	47	83	42	63	65	117	143	205	216
	121	179	35	62	39	52	52	79	87	116	128
	-6	-7	11	21	4	11	13	38	56	90	88
OPM %	-5.5%	-5.5%	8.9%	16.5%	5.1%	14.8%	17%	30.9%	37%	41.8%	37.8%
Depreciation	—	—	4	3	3	4	5	6	7	10	12
Interest	—	0	0	0	0	0	0	0	1	2	2
	4	5	37	29	93	10	89	54	55	75	73
Profit before tax	25	27	44	48	94	17	97	85	103	152	147
Tax	1	-1	2	4	0	3	12	6	10	10	22
Tax %	2.4%	-3.3%	5.4%	8.7%	0.1%	19.1%	11.9%	6.7%	9.6%	6.6%	15.2%
	25	28	42	43	94	13	86	79	93	142	125
PAT margin %	21.6%	21.2%	33.3%	34.1%	127%	18.5%	112.8%	64.4%	61%	66.2%	53.7%
EPS (₹)	0.9	1	1.6	1.7	3.6	0.5	3.3	3.1	3.6	5.5	4.9
EPS adjusted (₹)	—	1	1.6	1.7	3.6	0.5	3.3	3.1	3.6	5.5	4.9
	16.1%	19.2%	12.8%	11.8%	16.5%	38.5%	53.9%	71.2%	66.3%	43.4%	49.5%
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	53	53	51	51	51	51	51	51	51	51
Reserves	314	395	—	432	775	962	778	757	802	770
	—	—	—	0	0	0	0	9	14	11
	81	73	—	51	109	130	119	128	142	126
Total equity & liabilities	449	522	—	534	936	1,144	948	946	1,010	958
	—	—	131	131	134	134	132	131	135	170
CWIP	0	—	—	3	6	0	0	1	0	2
Investments	189	276	—	292	709	886	689	646	685	648
	260	246	—	109	88	124	127	168	190	138
Total assets	449	522	—	534	936	1,144	948	946	1,010	958

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.

Source XBRL ↗

Latest reported period · 31 Mar 2026 · ₹ crore

Segment	Revenue	Result	Assets	Liabilities	Capital employed	ROCE %
Real Estate Business	185.35	78.59	501.65	71.9	429.75	18.29
Active Pharmaceutical Ingredients Business	46.59	5.65

Alembic Limited

Segment results

Compounded sales growth

Compounded profit growth

Return on equity

Active Pharmaceutical Ingredients Business · revenue

₹ Cr	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	52	24	22	5	-1	-22	35	25	81	117
	-47	-23	72	57	-35	23	11	23	-22	-52
	-5	-3	-89	-6	-15	-6	-46	-48	-58	-67
Net cash flow	-0	-2	1	56	-51	-5	-0	0	2	-1
Free cash flow	—	—	—	-17	-8	-23	35	24	74	79
CFO / Operating profit %	—	213.2%	102.3%	147.3%	-10.4%	-169.4%	91.3%	45%	90.5%	133.9%

Alembic Limited

Profit & loss

Balance sheet

Segment results

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

Active Pharmaceutical Ingredients Business · revenue